Clinical Trials

New Search
Title   A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Disease/Condition   Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Sun Young Oh, MD
Contact Name   Amanda Erakky
Contact Email   aerakky@montefiore.org
IRB/Protocol Number   2016-7022
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Medical and Hematologic Oncology - Breast